Changes of plasma levels of soluble VEGFR2 and SOD in hypertensive patients and hypertensive diabetic patients

AIM: To explore the changes of plasma levels of soluble vascular endothelial growth factor receptor 2 (sVEGFR2) and superoxide dismutase (SOD) in hypertensive patients and hypertensive diabetic patients. METHODS: In this cross-sectional study, 88 cases were enrolled, which were divided into hypertensive group (n=31), hypertensive diabetic group (n=31) and control group (n=26). Blood pressure was obtained from each participant with mercury sphygmomanometer. The levels of sVEGFR2 and SOD were measured by ELISA. Meanwhile, the levels of plasma glucose, glycosylated hemoglobin A1c (GHbA1c) and lipid profile were detected. RESULTS: The levels of total cholesterol (TC) and body mass index (BMI) were significantly higher in hypertensive group than those in control group (P<0.05). The levels of TC, low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), BMI, waist circumference were significantly higher in hypertensive diabetic group than those in control group (P<0.05). The plasma levels of sVEGFR2 and SOD in both hypertensive diabetic group and hypertensive group were significantly decreased compared with control group (P<0.05), while the mean plasma levels of sVEGFR2 and SOD in hypertensive diabetic group were significantly decreased compared to the hypertensive group (P<0.05). A significantly positive correlation between sVEGFR2 and SOD in the whole study population (P<0.05) was observed. CONCLUSION: The plasma level of sVEGFR2 is decreased in both hypertensive and hypertensive diabetic patients, and more significantly decreased in hypertensive diabetic patients. Decreased SOD level may be associated with to the reduction of sVEGFR2.